ArticleCardiology journal2025

ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design.

Danuta Łoboda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.